Award
NIH Reporter #5R01CA272490-04
Mitochondrial NAD+ in Acute Myeloid Leukemias
Recipient
University of Texas at Austin, Internal Medicine/Medicine
Award Amount
$522,539.00
Ceiling
$522,539.00
Awarded
August 24, 2023
Identifier
5R01CA272490-04
Award for research on mitochondrial NAD+ in acute myeloid leukemias, focusing on the SLC25A51 transporter, funded by the National Cancer Institute for a project running from 2023 to 2028 with a total amount of $522,539.
Description
The project investigates mitochondrial NAD+ in AML, focusing on the role of SLC25A51 transporter. The award is from the National Cancer Institute, with a focus on cancer cell biology. The project duration is from August 24, 2023, to July 31, 2028. The project aims to establish a rationale for targeting mitochondrial NAD+ as a therapeutic approach for AML.